MYCN and neuroblastoma: Considering EZH2 as a potential epigenetic repressor of RUNX3, there could be a regulatory mechanism for the MYCN protein by mutually exclusive binding to oncogenic EZH2 or tumor-suppressive RUNX3 in neuroblastomas.